| Literature DB >> 33466141 |
Aliah M Alhayyan1, Stephen T McSorley2, Rachel J Kearns3, Paul G Horgan4, Campbell S D Roxburgh2, Donald C McMillan5.
Abstract
ABSTRACT: There are reports that the use of regional anesthesia (RA) may be associated with better perioperative surgical stress response in cancer patients compared with general anesthetics (GA). However, the role of anesthesia on the magnitude of the postoperative systemic inflammatory response (SIR) in colorectal cancer patients, within an enhanced recovery pathway (ERP), is not clear.The aim of the present study was to examine the effect of anesthesia, within an enhanced recovery pathway, on the magnitude of the postoperative SIR in patients undergoing elective surgery for colorectal cancer.Database of 507 patients who underwent elective open or laparoscopic colorectal cancer surgery between 2015 and 2019 at a single center was studied. The anesthetic technique used was categorized into either GA or GA + RA using a prospective proforma. The relationship between each anesthetic technique and perioperative clinicopathological characteristics was examined using binary logistic regression analysis.The majority of patients were male (54%), younger than 65 years (41%), either normal or overweight (64%), and were nonsmokers (47%). Also, the majority of patients underwent open surgery (60%) and received mainly general + regional anesthetic technique (80%). On univariate analysis, GA + RA was associated with a lower day 4 CRP (≤150/>150 mg/L) concentration. On day 4, postoperative CRP was associated with anesthetic technique [odds ratio (OR) 0.58; confidence interval (CI) 0.31-1.07; P = .086], age (OR 0.70; CI 0.50-0.98; P = .043), sex (OR 1.15; CI 0.95-2.52; P = .074), smoking (OR 1.57; CI 1.13-2.19; P = .006), preoperative mGPS (OR 1.55; CI 1.15-2.10; P = .004), and preoperative dexamethasone (OR 0.70; CI 0.47-1.03; P = .072). On multivariate analysis, day 4 postoperative CRP was independently associated with anesthetic technique (OR 0.56; CI 0.32-0.97; P = .039), age (OR 0.74; CI 0.55-0.99; P = .045), smoking (OR 1.58; CI 1.18-2.12; P = .002), preoperative mGPS (OR 1.41; CI 1.08-1.84; P = .012), and preoperative dexamethasone (OR 0.68; CI 0.50-0.92; P = .014).There was a modest but an independent association between RA and a lower magnitude of the postoperative SIR. Future work is warranted with multicenter RCT to precisely clarify the relationship between anesthesia and the magnitude of the postoperative SIR.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33466141 PMCID: PMC7808526 DOI: 10.1097/MD.0000000000023997
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
Pro-forma for patients undergoing surgery for elective open or laparoscopic surgery of colorectal cancer.
| 1- | CRC master number | ||||||
| 2- | CHI | ||||||
| 3- | Age | □ <65 | □ 65–74 | □ >75 | |||
| 4- | Sex | □ male | □ female | ||||
| 5- | BMI | □ <20 | □ 20–25 | □ 26–30 | □ >30 | ||
| 6- | Smoking | □ never | □ ex | □ current | |||
| 7- | ASA grade | □ 1 | □ 2 | □ 3 | □ 4 | ||
| 8- | TNM stage | □ 1 | □ 2 | □ 3 | □ 4 | ||
| 1- | Tumor site | □ right | □ left | ||||
| 1- | Preop mGPS | □ 0 | □ 1 | □ 2 | |||
| 11- | Open surgery | □ no | □ yes | ||||
| Laparoscopic surgery | □ no | □ yes | |||||
| 12- | Induction agent | □ Inhalational | □ Propofol | □ Thiopentone | □ Etomidate | ||
| 13- | Total intravenous anesthesia | □ no | □ yes, if yes specify | □ Propofol TCI | □ Propofol TCI+remifentanil | ||
| 14- | Inhalational anesthesia | □ no | □ yes, if yes specify | □ Sevoflurane | □ Desflurane | □ Isoflurane | |
| 15- | Remifentanil | □ no | □ yes TCI | ||||
| 16- | Total dose of opioid in theater | □ morphine 25 mg | □ fentanyl ___mg | ||||
| 17- | General + epidural | □ no | □ yes, if yes specify | □ plain bupivacaine bag | □ bupivacaine and opioid | ||
| 18- | General + Abdo wall-block | □ no | □ yes, if yes specify | □ TAP block | □ TAP catheter | □ Rectus sheath block | □ Rectus sheath catheter |
| 19- | General + local infiltration | □ no | □ yes, if yes specify | □ Simple local infiltration | □ Wound infiltration catheters | ||
| 20- | General + spinal | □ no | □ yes, if yes specify | □ Local anesthetic + opioid | □ Opioid alone | ||
| 21- | Dexamethasone given in theatre | □ no | □ yes | ||||
| 22- | NSAID/COX 2 given in theater | □ no | □ yes, if yes specify | □ Diclofenac | □ Ketorolac | □ Others_________ | |
| 23- | IV local anesthetics given in theater | □ no | □ yes | ||||
| 24- | NSAID / COX2 Given post-op? | □ no | □ yes, if yes specify | □ Diclofenac | □ Ibuprofen | □ Others _________ | |
| 25- | Steroids given post-op? | □ no | □ yes, if yes specify, dose _____mg | ||||
| 26- | Morphine Given post-op? | □ no | □ yes, if yes specify Total dose in 72 h = _____ mg (this will be a combination of oral and IV. Need to work out equivalent IV dose) | ||||
| 27- | Neostigmine/glycopyrrolate | □ no | □ yes | ||||
| 28- | Amoxicillin + Gentamicin + Metronidazole | □ no | □ yes | ||||
| 29- | Muscle relaxant | □ no | □ yes | ||||
| 30- | Midazolam | □ no | □ yes | ||||
| 31- | POD 2 CRP >150 mg/L | □ no | □ yes | ||||
| 32- | POD 3 CRP >150 mg/L | □ no | □ yes | ||||
| 33- | POD 4 CRP >150 mg/L | □ no | □ yes | ||||
| 34- | Neoadjuvant therapy | □ no | □ yes | ||||
| 35- | Adjuvant therapy | □ no | □ yes | ||||
| 36- | Stoma type | □ no | □ ileostomy | □ colostomy | |||
| 37- | Any complication | □ no | □ yes | ||||
| 38- | Infective complications | □ no | □ yes | ||||
| 39- | Clavien-Dindo grade | □ 0 | □ 1–2 | □ 3–4 | □ |
The relationship between general versus general + regional anesthesia and clinicopathological variables in patients undergoing elective surgery for colorectal cancer in ERP (n = 507).
| Characteristic | GA (n = 99) | GA + RA (n = 408) | |
| Age | .80 | ||
| <65 | 40 (40) | 167 (41) | |
| 65–74 | 36 (36) | 135 (33) | |
| >75 | 23 (23) | 106 (26) | |
| Sex | .09 | ||
| Male | 60 (61) | 215 (53) | |
| Female | 39 (39) | 193 (47) | |
| BMI | .26 | ||
| <20 | 3 (3) | 21 (5) | |
| 20–25 | 38 (39) | 104 (26) | |
| 26–30 | 28 (29) | 149 (37) | |
| >30 | 28 (29) | 125 (31) | |
| Smoking | .56 | ||
| Never | 45 (47) | 190 (47) | |
| Ex | 31 (33) | 154 (38) | |
| Current | 19 (20) | 60 (15) | |
| ASA grade | .24 | ||
| 1 | 10 (10) | 37 (9) | |
| 2 | 47 (47) | 208 (53) | |
| 3 | 35 (35) | 138 (35) | |
| 4 | 7 (7) | 10 (2) | |
| TNM stage | .003 | ||
| I | 26 (28) | 79 (20) | |
| II | 41 (44) | 129 (32) | |
| III | 20 (21) | 155 (39) | |
| IV | 4 (4) | 29 (7) | |
| Surgical approach | .02 | ||
| Open | 50 (51) | 254 (62) | |
| Laparoscopic | 49 (49) | 154 (38) | |
| Tumor site | .49 | ||
| Colon | 65 (65) | 244 (60) | |
| Rectum | 34 (34) | 162 (40) | |
| Preop mGPS | .61 | ||
| 0 | 61 (63) | 261 (65) | |
| 1 | 17 (17) | 66 (17) | |
| 2 | 19 (19) | 71 (18) | |
| Opioids | .10 | ||
| No | 1 (1) | 17 (4) | |
| Yes | 97 (99) | 390 (96) | |
| Preop Dexamethasone | .05 | ||
| No | 38 (39) | 95 (23) | |
| Yes | 60 (61) | 313 (77) | |
| POD 2 CRP > 150 mg/L | 47 (51) | 217 (54) | .23 |
| No | 45 (49) | 171 (44) | |
| Yes | |||
| POD 3 CRP > 150 mg/L | .34 | ||
| No | 47 (55) | 222 (58) | |
| Yes | 39 (45) | 163 (42) | |
| POD 4 CRP > 150 mg/L | .005 | ||
| No | 42 (56) | 254 (72) | |
| Yes | 33 (44) | 98 (28) | |
| Neoadjuvant therapy | .006 | ||
| No | 90 (94) | 339 (84) | |
| Yes | 6 (6) | 66 (16) | |
| Adjuvant therapy | .06 | ||
| No | 59 (61) | 212 (52) | |
| Yes | 37 (38) | 194 (48) | |
| Stoma type | .59 | ||
| No | 63 (64) | 245 (60) | |
| Ileostomy | 22 (22) | 96 (24) | |
| Colostomy | 14 (14) | 63 (15) | |
| Any complication | .30 | ||
| No | 65 (66) | 282 (70) | |
| Yes | 33 (34) | 123 (30) | |
| Infective complication | .54 | ||
| No | 75 (76) | 311 (76) | |
| Yes | 23 (23) | 95 (23) | |
| Clavien-Dindo grade | .94 | ||
| 0 | 56 (57) | 209 (51) | |
| 1–2 | 29 (30) | 148 (36) | |
| 3–4 | 10 (10) | 45 (11) | |
| 5 | 3 (3) | 4 (1) |
ASA = American Society of Anaesthesiology Grading system, BMI = body mass index, CRP = C-reactive protein, day = G General anesthesia, E = Epidural anesthesia, POD = postoperative, Preop mGPS = preoperative modified Glasgow Prognostic score, RA = Regional anesthesia, Sp = Spinal anesthesia, TNM = Tumour Node Metastases, (0 = no complication, 1–2 = complication with minor intervention, 3–4 = complication with major intervention, 5 = death).
The relationship between general versus general + regional anesthesia and clinicopathological variables in patients undergoing elective surgery for colon cancer in ERP (n = 309).
| Characteristic | GA (n = 65) | GA + RA (n = 244) | |
| Age, yr | .65 | ||
| <65 | 25 (38) | 84 (34) | |
| 65–74 | 22 (34) | 90 (37) | |
| >75 | 18 (28) | 70 (29) | |
| Sex | .43 | ||
| Male | 35 (54) | 126 (52) | |
| Female | 30 (46) | 118 (48) | |
| BMI | .29 | ||
| <20 | 3 (5) | 13 (5) | |
| 20–25 | 27 (41) | 62 (26) | |
| 26–30 | 14 (21) | 87 (37) | |
| >30 | 21 (32) | 76 (32) | |
| Smoking | .60 | ||
| Never | 30 (48) | 114 (47) | |
| Ex | 22 (35) | 98 (41) | |
| Current | 11 (17) | 29 (12) | |
| ASA grade | .11 | ||
| 1 | 4 (6) | 19 (8) | |
| 2 | 28 (43) | 116 (49) | |
| 3 | 27 (41) | 91 (39) | |
| 4 | 6 (9) | 9 (4) | |
| TNM stage | .14 | ||
| I | 14 (22) | 47 (20) | |
| II | 29 (46) | 84 (35) | |
| III | 17 (27) | 83 (35) | |
| IV | 3 (5) | 22 (9) | |
| Surgical approach | .01 | ||
| Open | 32 (49) | 159 (65) | |
| Laparoscopic | 33 (51) | 85 (35) | |
| Preop mGPS | .57 | ||
| 0 | 36 (57) | 141 (59) | |
| 1 | 11 (17) | 47 (20) | |
| 2 | 16 (25) | 50 (21) | |
| Opioids | .63 | ||
| No | 1 (2) | 5 (2) | |
| Yes | 63 (98) | 239 (98) | |
| Preop Dexamethasone | .49 | ||
| No | 26 (40) | 68 (28) | |
| Yes | 39 (60) | 176 (72) | |
| POD 2 CRP > 150 mg/L | .26 | ||
| No | 31 (48) | 124 (53) | |
| Yes | 34 (52) | 110 (47) | |
| POD 3 CRP > 150 mg/L | .40 | ||
| No | 32 (53) | 128 (56) | |
| Yes | 28 (47) | 100 (44) | |
| POD 4 CRP > 150 mg/L | .01 | ||
| No | 27 (53) | 146 (70) | |
| Yes | 24 (47) | 63 (30) | |
| Neoadjuvant therapy | .24 | ||
| No | 63 (98) | 231 (95) | |
| Yes | 1 (2) | 11 (5) | |
| Adjuvant therapy | .47 | ||
| No | 36 (56) | 133 (55) | |
| Yes | 28 (44) | 110 (45) | |
| Stoma type | .22 | ||
| No | 48 (74) | 196 (81) | |
| Ileostomy | 13 (20) | 34 (14) | |
| Colostomy | 4 (6) | 11 (5) | |
| Any complication | .40 | ||
| No | 43 (66) | 166 (69) | |
| Yes | 22 (34) | 76 (31) | |
| Infective complication | .45 | ||
| No | 50 (77) | 190 (79) | |
| Yes | 15 (23) | 52 (21) | |
| Clavien-Dindo grade | .81 | ||
| 0 | 38 (58) | 126 (58) | |
| 1–2 | 19 (29) | 90 (37) | |
| 3–4 | 5 (8) | 23 (9) | |
| 5 | 3 (5) | 3 (1) |
ASA = American Society of Anaesthesiology Grading system, BMI = body mass index, CRP = C-reactive protein, day, G = General anesthesia, E = Epidural anesthesia, POD = postoperative, Preop mGPS = preoperative modified Glasgow Prognostic score, RA = Regional anesthesia, Sp = Spinal anesthesia, TNM = Tumour Node Metastases, (0 = no complication, 1–2 = complication with minor intervention, 3–4 = complication with major intervention, 5 = death).
Binary logistic regression of clinicopathological data associated with low versus high POD 4 CRP concentrations in patients undergoing elective surgery for colorectal cancer in ERP (n = 507).
| Variables | Univariate analysis OR (95% CI) | Multivariate analysis OR (95% CI) | ||
| Age, yr (<65/65–74/>75) | 0.70 (0.50–0.98) | .043 | 0.74 (0.55–0.99) | .045 |
| Sex (male/female) | 1.15 (0.95–2.52) | .074 | 1.48 (0.94–2.31) | .085 |
| BMI (<20/20–25/26–30/>30) | 1.17 (0.89–1.53) | .253 | – | – |
| Smoking (never/ex/current) | 1.57 (1.13–2.19) | .006 | 1.58 (1.18–2.12) | .002 |
| ASA grade (1/2/3/4) | 0.82 (0.56–1.20) | .311 | – | – |
| Surgical technique (open/laparoscopic) | 0.72 (0.39–1.34) | .310 | – | – |
| TNM stage (I/II/III/IV) | 0.93 (0.71–1.21) | .594 | – | – |
| Opioids (no/yes) | 1.12 (0.35–3.60) | .842 | – | – |
| Tumor site (colon/rectum) | 0.89 (0.74–1.07) | .221 | – | – |
| Preop mGPS (0/1/2) | 1.55 (1.15–2.10) | .004 | 1.41 (1.08–1.84) | .012 |
| GA alone /GA+ RA (no/yes) | 0.58 (0.31–1.07) | .086 | 0.56 (0.32–0.97) | .039 |
| Preop Dexamethasone (no/yes) | 0.70 (0.47–1.03) | .072 | 0.68 (0.50–0.92) | .014 |